PAPER Caglayan S, Takagi-Niidome S, Liao F, Carlo AS, Schmidt V, Burgert T, Kitago Y, Füchtbauer EM, Füchtbauer A, Holtzman DM, Takagi J, Willnow TE
SEARCH RESULTS
331259 RESULTS
Jonas Neher
German Center for Neurodegenerative Diseases (DZNE)Tuebingen , Germany
Tomas Falzone
CONICETDuenos Aires, Argentina
Brendan Innes
Massachusetts General HospitalBoston, United States
PAPER Kappeler L, De Magalhaes Filho C, Dupont J, Leneuve P, Cervera P, Périn L, Loudes C, Blaise A, Klein R, Epelbaum J, Le Bouc Y, Holzenberger M
Brain IGF-1 receptors control mammalian growth and lifespan through a neuroendocrine mechanism.
PLoS Biol. 2008 Oct 28;6(10):e254. PubMed: 18959478PAPER Holzenberger M, Dupont J, Ducos B, Leneuve P, Géloën A, Even PC, Cervera P, Le Bouc Y
IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice.
Nature. 2003 Jan 9;421(6919):182-7. Epub 2002 Dec 4 PubMed: 12483226PAPER Forsyth PA, Krishna N, Lawn S, Valadez JG, Qu X, Fenstermacher DA, Fournier M, Potthast L, Chinnaiyan P, Gibney GT, Zeinieh M, Barker PA, Carter BD, Cooper MK, Kenchappa RS
p75 neurotrophin receptor cleavage by α- and γ-secretases is required for neurotrophin-mediated proliferation of brain tumor-initiating cells.
J Biol Chem. 2014 Mar 21;289(12):8067-85. Epub 2014 Feb 11 PubMed: 24519935PAPER Gjerde KV, Tysnes OB
[Genetic coherence between hereditary amyotrophic lateral sclerosis and frontotemporal dementia].
Tidsskr Nor Laegeforen. 2014 Feb 11;134(3):302-6. PubMed: 24518478PAPER Chen JM, Chang CW, Chang TH, Hsu CC, Horng JT, Sheu WH
Effects of statins on incident dementia in patients with type 2 DM: a population-based retrospective cohort study in Taiwan.
PLoS One. 2014;9(2):e88434. Epub 2014 Feb 10 PubMed: 24520388PAPER Qiu WQ, Wallack M, Dean M, Liebson E, Mwamburi M, Zhu H
Association between amylin and amyloid-β peptides in plasma in the context of apolipoprotein E4 allele.
PLoS One. 2014;9(2):e88063. Epub 2014 Feb 10 PubMed: 24520345PAPER Rijal Upadhaya A, Kosterin I, Kumar S, von Arnim CA, Yamaguchi H, Fändrich M, Walter J, Thal DR
Biochemical stages of amyloid-β peptide aggregation and accumulation in the human brain and their association with symptomatic and pathologically preclinical Alzheimer's disease.
Brain. 2014 Mar;137(Pt 3):887-903. Epub 2014 Feb 10 PubMed: 24519982PAPER Dohler F, Sepulveda-Falla D, Krasemann S, Altmeppen H, Schlüter H, Hildebrand D, Zerr I, Matschke J, Glatzel M
High molecular mass assemblies of amyloid-β oligomers bind prion protein in patients with Alzheimer's disease.
Brain. 2014 Mar;137(Pt 3):873-86. Epub 2014 Feb 10 PubMed: 24519981PAPER Iulita MF, Do Carmo S, Ower AK, Fortress AM, Flores Aguilar L, Hanna M, Wisniewski T, Granholm AC, Buhusi M, Busciglio J, Cuello AC
Nerve growth factor metabolic dysfunction in Down's syndrome brains.
Brain. 2014 Mar;137(Pt 3):860-72. Epub 2014 Feb 11 PubMed: 24519975PAPER Hureau C, Faller P
Platinoid complexes to target monomeric disordered peptides: a forthcoming solution against amyloid diseases?
Dalton Trans. 2014 Mar 21;43(11):4233-7. PubMed: 24519324PAPER Kim JH, Ha TL, Im GH, Yang J, Seo SW, Chung JJ, Chae SY, Lee IS, Lee JH
Magnetic resonance imaging for monitoring therapeutic response in a transgenic mouse model of Alzheimer's disease using voxel-based analysis of amyloid plaques.
Neuroreport. 2014 Mar 5;25(4):211-8. PubMed: 24518227Current Filters
No filters selected